BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25796583)

  • 1. Differences in genetic variation in antigen-processing machinery components and association with cervical carcinoma risk in two Indonesian populations.
    Mehta AM; Spaans VM; Mahendra NB; Osse EM; Vet JN; Purwoto G; Surya IG; Cornian S; Peters AA; Fleuren GJ; Jordanova ES
    Immunogenetics; 2015 Jun; 67(5-6):267-75. PubMed ID: 25796583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation of antigen processing machinery components and association with cervical carcinoma.
    Mehta AM; Jordanova ES; van Wezel T; Uh HW; Corver WE; Kwappenberg KM; Verduijn W; Kenter GG; van der Burg SH; Fleuren GJ
    Genes Chromosomes Cancer; 2007 Jun; 46(6):577-86. PubMed ID: 17366619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single nucleotide polymorphisms in antigen processing machinery component ERAP1 significantly associate with clinical outcome in cervical carcinoma.
    Mehta AM; Jordanova ES; Corver WE; van Wezel T; Uh HW; Kenter GG; Jan Fleuren G
    Genes Chromosomes Cancer; 2009 May; 48(5):410-8. PubMed ID: 19202550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transcriptional and epigenetic regulation of antigen processing machinery (APM) components and HLA-I in cervical cancers from Uighur women.
    Hasim A; Abudula M; Aimiduo R; Ma JQ; Jiao Z; Akula G; Wang T; Abudula A
    PLoS One; 2012; 7(9):e44952. PubMed ID: 23024775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in HLA class I antigen-processing genes and susceptibility to human papillomavirus type 16-associated cervical cancer.
    Deshpande A; Wheeler CM; Hunt WC; Peyton CL; White PS; Valdez YE; Nolan JP
    J Infect Dis; 2008 Feb; 197(3):371-81. PubMed ID: 18248301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of Antigen-Presenting Machinery Genes in Non-Small Cell Lung Cancer: Different Impact on Disease Risk and Clinical Parameters in Smokers and Never-Smokers.
    Wiśniewski A; Sobczyński M; Pawełczyk K; Porębska I; Jasek M; Wagner M; Niepiekło-Miniewska W; Kowal A; Dubis J; Jędruchniewicz N; Kuśnierczyk P
    Front Immunol; 2021; 12():664474. PubMed ID: 34149699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma.
    Mehta AM; Jordanova ES; Kenter GG; Ferrone S; Fleuren GJ
    Cancer Immunol Immunother; 2008 Feb; 57(2):197-206. PubMed ID: 17622526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China.
    Cao B; Tian X; Li Y; Jiang P; Ning T; Xing H; Zhao Y; Zhang C; Shi X; Chen D; Shen Y; Ke Y
    Carcinogenesis; 2005 Jul; 26(7):1280-4. PubMed ID: 15774487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical Carcinogenesis and Immune Response Gene Polymorphisms: A Review.
    Mehta AM; Mooij M; Branković I; Ouburg S; Morré SA; Jordanova ES
    J Immunol Res; 2017; 2017():8913860. PubMed ID: 28280748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic investigation of contribution of genetic variation in the HLA-DP region to cervical cancer susceptibility.
    Chen D; Gyllensten U
    Carcinogenesis; 2014 Aug; 35(8):1765-9. PubMed ID: 24743517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in transporter associated with antigen presenting are associated with cervical intraepithelial neoplasia and cervical cancer in a Chinese Han population.
    Yang J; Liu W; Yan Z; Li C; Liu S; Yang X; Li Y; Shi L; Yao Y
    HLA; 2021 Jul; 98(1):23-36. PubMed ID: 34050605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte antigen class II alleles and risk of cervical cancer in China.
    Wu Y; Liu B; Lin W; Xu Y; Li L; Zhang Y; Chen S; Lin Z; Xu A
    Hum Immunol; 2007 Mar; 68(3):192-200. PubMed ID: 17349874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in CXCL12 and risk of cervical carcinoma: a population-based case-control study.
    Maley SN; Schwartz SM; Johnson LG; Malkki M; Du Q; Daling JR; Li SS; Zhao LP; Petersdorf EW; Madeleine MM
    Int J Immunogenet; 2009 Dec; 36(6):367-75. PubMed ID: 19788587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in Processing and Antigen Presentation-Related Genes and Their Association with Host Susceptibility to Influenza A/H1N1 2009 Pandemic in a Mexican Mestizo Population.
    Ponce-Gallegos MA; Ruiz-Celis A; Ambrocio-Ortiz E; Pérez-Rubio G; Ramírez-Venegas A; Bautista-Félix NE; Falfán-Valencia R
    Viruses; 2020 Oct; 12(11):. PubMed ID: 33138079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An interleukin-10 gene polymorphism associated with the development of cervical lesions in women infected with Human Papillomavirus and using oral contraceptives.
    Chagas BS; Gurgel AP; da Cruz HL; Amaral CM; Cardoso MV; Silva Neto Jda C; da Silva LA; de Albuquerque EM; Muniz MT; de Freitas AC
    Infect Genet Evol; 2013 Oct; 19():32-7. PubMed ID: 23800422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of immunological genes on chromosome 2q33 and IFNG in susceptibility to cervical cancer.
    Ivansson EL; Juko-Pecirep I; Gyllensten UB
    Gynecol Oncol; 2010 Mar; 116(3):544-8. PubMed ID: 19959217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV16 E6 variants and HLA class II polymorphism among Chinese women with cervical cancer.
    Wu Y; Liu B; Lin W; Xu Y; Li L; Zhang Y; Chen S; Xu A
    J Med Virol; 2007 Apr; 79(4):439-46. PubMed ID: 17311339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA-4 gene polymorphism at position +49 A>G in exon 1: a risk factor for cervical cancer in Indian women.
    Gokhale P; Kerkar S; Tongaonkar H; Salvi V; Mania-Pramanik J
    Cancer Genet; 2013 May; 206(5):154-61. PubMed ID: 23830732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Expression of the Antigen Processing Machinery Components TAP2, LMP2, and LMP7 in Tonsillar and Base of Tongue Cancer and Implications for Clinical Outcome.
    Tertipis N; Haeggblom L; Grün N; Nordfors C; Näsman A; Dalianis T; Ramqvist T
    Transl Oncol; 2015 Feb; 8(1):10-7. PubMed ID: 25749172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How about the uncertainty in the haplotypes in the population-based KORA studies?].
    Heid IM; Lamina C; Bongardt F; Fischer G; Klopp N; Huth C; Küchenhoff H; Kronenberg F; Wichmann HE; Illig T
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S132-6. PubMed ID: 16032531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.